AR069943A1 - Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium - Google Patents
Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacteriumInfo
- Publication number
- AR069943A1 AR069943A1 ARP080105678A ARP080105678A AR069943A1 AR 069943 A1 AR069943 A1 AR 069943A1 AR P080105678 A ARP080105678 A AR P080105678A AR P080105678 A ARP080105678 A AR P080105678A AR 069943 A1 AR069943 A1 AR 069943A1
- Authority
- AR
- Argentina
- Prior art keywords
- circumstance
- administration
- reducing abdominal
- bifidobacterium bacteria
- reducing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 241000186000 Bifidobacterium Species 0.000 title abstract 2
- 230000003187 abdominal effect Effects 0.000 title abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Método para reducir la circunferencia abdominal en un individuo mediante la administracion de un probiotico, de preferencia una bacteria del género Bifidobacterium, siendo dicho método en un aspecto, un método no terapéutico, y de acuerdo con otro aspecto, un método para tratar SII (síndrome del intestino irritable).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1582007P | 2007-12-21 | 2007-12-21 | |
| EP07301736A EP2072053B1 (en) | 2007-12-21 | 2007-12-21 | Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069943A1 true AR069943A1 (es) | 2010-03-03 |
Family
ID=39327067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105678A AR069943A1 (es) | 2007-12-21 | 2008-12-22 | Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100303763A1 (es) |
| EP (2) | EP2072053B1 (es) |
| JP (2) | JP2011507496A (es) |
| KR (2) | KR20160011234A (es) |
| CN (1) | CN101977614A (es) |
| AR (1) | AR069943A1 (es) |
| ES (1) | ES2395838T3 (es) |
| PL (1) | PL2072053T3 (es) |
| RU (1) | RU2491946C2 (es) |
| WO (1) | WO2009080800A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
| BRPI1014304A2 (pt) * | 2009-05-11 | 2016-04-05 | Nestec Sa | bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes |
| CN102711778B (zh) * | 2009-11-02 | 2015-06-24 | 热尔韦法国达能公司 | 利用动物双歧杆菌细菌或含有这种细菌的发酵乳制品减轻胃肠炎症的方法 |
| WO2011148220A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving transepithelial resistance |
| WO2011148219A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
| EP2651423B1 (en) | 2010-12-17 | 2015-09-30 | Compagnie Gervais Danone | Lactococcus lactis strains for use in improving digestive condition |
| CN104822277A (zh) * | 2012-11-29 | 2015-08-05 | 雀巢产品技术援助有限公司 | 合生元组合物及其用途 |
| EP3104868A2 (fr) * | 2014-02-14 | 2016-12-21 | Vesale Pharma Sa | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 |
| RU2613125C1 (ru) * | 2016-04-11 | 2017-03-15 | Оксана Владимировна Крапивная | Способ лечения синдрома раздраженного кишечника с запором, ассоциированного синдромом избыточного бактериального роста |
| RU2644634C1 (ru) * | 2017-03-07 | 2018-02-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) | Способ лечения больных с клиническими проявлениями синдрома раздраженного кишечника |
| US10376200B2 (en) * | 2017-09-28 | 2019-08-13 | Hong Min Kim | System for detecting and logging of flatulence for health indication |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| FR2808689B1 (fr) | 2000-05-11 | 2004-09-03 | Agronomique Inst Nat Rech | Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs |
| FR2811333B1 (fr) | 2000-07-04 | 2003-01-10 | Gervais Danone Sa | Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes |
| RU2223774C2 (ru) * | 2002-04-11 | 2004-02-20 | Закрытое акционерное общество "Партнер" | Способ коррекции дисбиотических расстройств у детей раннего возраста с диареями |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| RU2291194C2 (ru) * | 2003-03-17 | 2007-01-10 | Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" | Консорциум штаммов бифидобактерий, используемый для получения жидкого концентрата бифидобактерий, кисломолочных, неферментированных лечебно-профилактических продуктов, биологически активных добавок и бактерийных препаратов |
| US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
| ES2561629T3 (es) * | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
-
2007
- 2007-12-21 PL PL07301736T patent/PL2072053T3/pl unknown
- 2007-12-21 EP EP07301736A patent/EP2072053B1/en active Active
- 2007-12-21 ES ES07301736T patent/ES2395838T3/es active Active
-
2008
- 2008-12-19 JP JP2010538783A patent/JP2011507496A/ja active Pending
- 2008-12-19 CN CN2008801273761A patent/CN101977614A/zh active Pending
- 2008-12-19 KR KR1020167001100A patent/KR20160011234A/ko not_active Application Discontinuation
- 2008-12-19 EP EP08863726A patent/EP2224935A2/en not_active Withdrawn
- 2008-12-19 US US12/809,174 patent/US20100303763A1/en not_active Abandoned
- 2008-12-19 RU RU2010130299/15A patent/RU2491946C2/ru active
- 2008-12-19 KR KR1020107016395A patent/KR20100102178A/ko active Application Filing
- 2008-12-19 WO PCT/EP2008/068125 patent/WO2009080800A2/en active Application Filing
- 2008-12-22 AR ARP080105678A patent/AR069943A1/es unknown
-
2014
- 2014-01-10 JP JP2014003185A patent/JP5850956B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2072053T3 (pl) | 2013-02-28 |
| ES2395838T3 (es) | 2013-02-15 |
| EP2224935A2 (en) | 2010-09-08 |
| EP2072053A1 (en) | 2009-06-24 |
| RU2491946C2 (ru) | 2013-09-10 |
| WO2009080800A2 (en) | 2009-07-02 |
| US20100303763A1 (en) | 2010-12-02 |
| JP2014065743A (ja) | 2014-04-17 |
| CN101977614A (zh) | 2011-02-16 |
| KR20160011234A (ko) | 2016-01-29 |
| JP5850956B2 (ja) | 2016-02-03 |
| EP2072053B1 (en) | 2012-11-07 |
| RU2010130299A (ru) | 2012-01-27 |
| KR20100102178A (ko) | 2010-09-20 |
| JP2011507496A (ja) | 2011-03-10 |
| WO2009080800A3 (en) | 2010-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR069943A1 (es) | Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium | |
| ES2561253T3 (es) | Bacterias probióticas que tienen actividad antioxidante y uso de las mismas | |
| BR112018074795A2 (pt) | novo uso médico de probióticos | |
| ES2477882T3 (es) | Probióticos, IgA secretora e infección | |
| AR072435A1 (es) | Composicion nutricional para lactantes nacidos por cesarea | |
| UA97663C2 (ru) | Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения | |
| ATE526836T1 (de) | Nährstoffzusammensetzung mit probiotika | |
| CL2011000891A1 (es) | Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales. | |
| MY148872A (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
| MY162245A (en) | Nutrition with non-viable bifidabacterium and non-digestible | |
| NZ598751A (en) | Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175)) | |
| CL2012001080A1 (es) | Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida. | |
| EA201400119A1 (ru) | Фармацевтическая композиция, способы лечения и их применение | |
| MX337041B (es) | Cepas y metodos para mejorar la salud y/o desempeño de los rumiantes. | |
| AR079325A1 (es) | Metodo y aparato para duplicar sesion y compartir sesion | |
| BR112015011697A2 (pt) | antibióticos macrocíclicos de amplo espectro | |
| MX2010008555A (es) | Bacteria recombinante con sistema de secrecion de hemolisina de e-coli y expresion incrementada y/o secrecion de hiya. proceso de elaboracion y usos de la misma. | |
| CL2011002649A1 (es) | Uso de un aerosol que comprende levofloxacina u ofloxacina para preparar un medicamento util para el tratamiento de una infeccion bacteriana pulmonar. | |
| CO6731095A2 (es) | Composición farmacéutica de administración oral para el tratamiento del síndrome de intestino irritable digestivas a base de un modificador de la motilidad intestinal, un agente que previene la retención de gases y enzimas digestivas y proceso para su preparación | |
| ECSP077423A (es) | Coadministración de tigeciclina y digoxin | |
| PA8824601A1 (es) | Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia | |
| PL386175A1 (pl) | Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus | |
| FI20096400A0 (fi) | Veriryhmästatuksen käyttö I | |
| MX2009004113A (es) | Composicion que comprende un antagonista del receptor de neuroquinina-1 y un inhibidor selectivo de la recaptacion de serotonina para el tratamiento de tinnitus y perdida auditiva. | |
| UY33732A (es) | Composición farmacéutica a base de modificador de la motilidad intestinal y alfa-d-galactosidasa para el tratamiento del síndrome del intestino irritable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |